US 6756201
Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
expired A61PA61P35/00A61P35/04
Quick answer
US patent 6756201 (Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1) held by The United States of America as represented by the Department of Health and Services expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as represented by the Department of Health and Services
- Grant date
- Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P35/00, A61P35/04